LICENSING OPTIONS. For each MIT Invention on which a patent application is filed by MIT, MIT hereby grants Sponsor a non-exclusive, non-transferable, royalty-free license for internal research purposes. Sponsor shall further be entitled to elect one of the following license options by notice in writing to MIT within six (6) months after MIT’s notification to Sponsor that a patent application has been filed:
LICENSING OPTIONS. For each MIT Invention on which a patent application is filed by MIT, MIT hereby grants Sponsor a non-exclusive, non-transferable, royalty-free license for internal research purposes. Sponsor shall further be entitled to elect one of the following license options by notice in writing to MIT within six (6) months after MIT’s notification to Sponsor that a patent application has been filed: a non-exclusive, non-transferable, royalty-free license (in a designated field of use, where appropriate) to Sponsor, without the right to sublicense, in the United States and/or any foreign country elected by Sponsor pursuant to Section 11.C below, to make, have made, use, lease, sell and import products embodying or produced through the use of such MIT Invention; or a royalty-bearing, exclusive license (subject to third party rights, if any, and in a designated field of use, where appropriate) to Sponsor, including the right to sublicense, in the United States and/or any foreign country elected by Sponsor pursuant to Section 11.C below, to make, have made, use, lease, sell and import products embodying or produced through the use of such MIT Invention (or MIT’s interest in a Joint Invention). This option to elect an exclusive license is subject to MIT’s concurrence and the Parties’ negotiation of commercially reasonable license terms and conditions. Each of the foregoing licenses is subject to Sponsor’s agreement to (a) reimburse MIT for the costs of patent prosecution and maintenance in the United States and any elected foreign country, (b) demonstrate reasonable efforts to commercialize the technology in the public interest, and (c) comply with the requirements, if any, applicable under the Xxxx-Xxxx Xxx, 00 USC §200-212 and 37 CFR Part 401, as amended. If Sponsor and MIT do not enter into a license agreement within three (3) months after Sponsor’s election to proceed under Section 11.B.1 or 11.B.2 above, Sponsor’s rights under Sections 11.B.1 and 11.B.2 will expire.
LICENSING OPTIONS. For each UNIVERSITY Invention on which a patent application is filed by UNIVERSITY, UNIVERSITY hereby grants the FARDA a non-exclusive, non-transferable, royalty- free license for non-commercial internal research purposes. The FARDA shall further be entitled to elect an option to the following commercial license by notice in writing to UNIVERSITY within three (3) months after UNIVERSITY’s notification to the FARDA that a patent application has been filed:
LICENSING OPTIONS. The Licensing Options are as follows: • Harmony Single Site license (monthly) • Harmony Single Site license (yearly) Both licensing options include: • Application hosting • Data back up • Automatic software upgrades • Online video training and documents (Learning Path) • Online technical support • Phone support • CCS interface
LICENSING OPTIONS. Each party shall have the unrestricted right to license to third parties any such Joint Invention without accounting to the other party, except that the Sponsor shall be entitled to elect a license to M.I.T.'s interest as provided under paragraph 11.B. below. Licensing of Joint Inventions shall be governed by the terms and conditions set forth in a Joint Invention Agreement (hereinafter "Joint Invention Agreement") to be executed by the parties and appended hereto.
LICENSING OPTIONS a. Hindenburg offers 2 licensing options:
LICENSING OPTIONS. (i) Sponsor shall have a royalty-free, non-exclusive license to use UVM Inventions for research and development purposes.
LICENSING OPTIONS. WMC grants to the Sponsor an option to negotiate an exclusive, royalty-bearing license under the Medical College Inventions on reasonable terms and conditions to be agreed upon by the parties within sixty (60) days of receipt of the invention report.
LICENSING OPTIONS. 5.1 Sponsor’s Evaluation of Xxxx’x Intellectual Property. Intellectual Property owned by Rice resulting from the Research Project disclosed by Rice to Sponsor may be used by Sponsor on a non-exclusive royalty-free basis, solely for internal, non-commercial research purposes during the Project Period to evaluate whether or not Sponsor is interested in licensing the technology from Rice.
LICENSING OPTIONS. The Medical College hereby grants to Sponsor the exclusive right and option to negotiate with the Medical College for an exclusive, worldwide, right and license to make, have made, use and sell commercial products embodying any Medical College Invention(s), with the right to sublicense, for the lives of any patent issuing thereon, upon commercially reasonable terms. The Sponsor and the Medical College shall exercise reasonable efforts to agree to terms and conditions of such a license within sixty (60) days after Sponsor’s receipt of notice and disclosure of a Medical College Invention from the Medical College. If, after the end of the sixty (60) day period (or such additional period if agreed by both parties), Sponsor and the Medical College are unable to reach agreement on the terms of such a license, the Medical College shall thereafter be free to engage in license discussions and negotiations with third parties regarding such Medical College Invention(s).
